Genetic epidemiology of acute respiratory distress syndrome: implications for future prevention and treatment.
The genetic susceptibility to the development of and variable outcomes in acute lung injury/acute respiratory distress syndrome (ALI/ARDS) has become a topic of great interest in the pulmonary and critical care community. Published studies of variable genetic susceptibility to ALI/ARDS already have identified some important candidate genes and potential gene-environment interactions. This article reviews these recent studies, features of the current approach, and implications for future prevention and treatment in ALI. The challenges and potential contributions of genetic epidemiology to the future prevention and treatment in ALI are discussed.
Gong
Michelle Ng
MN
Pulmonary, Critical Care, and Sleep Medicine, Department of Medicine, Mount Sinai School of Medicine, New York, NY 10029, USA.
D015316:Genetic Therapy / Q000379:methods*; D006801:Humans; D015994:Incidence; D011110:Polymorphism, Genetic; D011379:Prognosis; D037701:Pulmonary Surfactant-Associated Protein B / Q000235:genetics*; D012128:Respiratory Distress Syndrome / Q000453:epidemiology / Q000235:genetics / Q000517:prevention & control
D037701:Pulmonary Surfactant-Associated Protein B